FSRH CEU new product review: Drovelis® estetrol/drospirenone combined oral contraceptive (October 2022)
... European/Russian phase III study[4], 9.1% discontinued because of apparent side effects of E4/DRSP. Drug interaction Key information: As with other CHC, the contraceptive effectiveness of E4/DRSP could be ...